Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 199,416 |
|
|||||
| News | - | ||||||
| Day High | 4.0055 | Low High |
|||||
| Day Low | 3.77 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| ChromaDex Corporation | CDXC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.20 | -5.04% | 3.77 | 19:34:24 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.99 | 3.77 | 4.0055 | 3.79 | 3.97 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,041 | 199,416 | $ 3.90 | $ 778,655 | - | 1.25 - 4.65 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:34:24 | formt | 300 | $ 3.77 | USD |
ChromaDex Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 285.42M | 75.31M | - | 83.57M | -4.94M | -0.07 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ChromaDex News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDXC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.01 | 4.19 | 3.62 | 3.95 | 297,661 | -0.24 | -5.99% |
| 1 Month | 2.99 | 4.65 | 2.95 | 3.84 | 461,890 | 0.78 | 26.09% |
| 3 Months | 1.47 | 4.65 | 1.45 | 3.09 | 310,053 | 2.30 | 156.46% |
| 6 Months | 1.31 | 4.65 | 1.25 | 2.75 | 180,030 | 2.46 | 187.79% |
| 1 Year | 1.42 | 4.65 | 1.25 | 2.35 | 133,107 | 2.35 | 165.49% |
| 3 Years | 8.14 | 10.78 | 1.15 | 4.20 | 310,521 | -4.37 | -53.69% |
| 5 Years | 3.97 | 23.66 | 1.15 | 8.39 | 488,307 | -0.20 | -5.04% |
ChromaDex Description
| ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors. |
